Siliq 210 mg/1
Brodalumab · INJECTION · Bausch Health US LLC
No Recall History
Plain English
Siliq is a injection containing brodalumab at 210 mg/1, taken subcutaneous. Manufactured by Bausch Health US LLC.
Key Facts
- Brand Name
- Siliq
- Generic Name
- Brodalumab
- NDC Code (Product)
0187-0004- Manufacturer
- Bausch Health US LLC
- Strength
- 210 mg/1
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761032
- Marketing Start
- 02/15/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Siliq used for?
Siliq contains Brodalumab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Siliq a controlled substance?
Siliq is not classified as a controlled substance by the DEA.
What is the generic name for Siliq?
The generic name for Siliq is Brodalumab. There are no other listed brand versions of Brodalumab.
What is the NDC code for Siliq 210 mg/1?
The NDC (National Drug Code) for Siliq 210 mg/1 is 0187-0004, listed by Bausch Health US LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)